Equities

Vaishali Pharma Ltd

VAISHALI:NSI

Vaishali Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)192.91
  • Today's Change-0.09 / -0.05%
  • Shares traded63.08k
  • 1 Year change+56.84%
  • Beta0.6936
Data delayed at least 15 minutes, as of Sep 20 2024 11:24 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue863697758
OPERATING EXPENSES
Cost of revenue total744547635
Selling, general and admin. expenses, total1062121
Depreciation/amortization5.085.044.56
Unusual expense(income)------
Other operating expenses, total0.023834
Total operating expense856610694
Operating income7.168664
Other, net3.842218
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes9.268857
Provision for income taxes2.072217
Net income after taxes7.196640
Minority interest------
Net income before extra. Items7.196640
Total extraordinary items------
Net income7.196640
Inc.avail. to common excl. extra. Items7.196640
Inc.avail. to common incl. extra. Items7.196640
EPS RECONCILIATION
Basic/primary weighted average shares111111
Basic/primary eps excl. extra items0.686.263.82
Basic/primary eps incl. extra items0.686.263.82
Dilution adjustment------
Diluted weighted average shares111111
Diluted eps excl. extra items0.685.913.82
Diluted eps incl. extra items0.685.913.82
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock0----
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental172025
SUPPLEMENTAL INCOME
Depreciation, supplemental3.853.973.31
Total special items------
NORMALISED INCOME
Normalized income before taxes9.268857
Effect of special items on income taxes------
Income tax excluding impact of special items2.072217
Normalized income after tax7.196640
Normalized income avail. to common7.196640
Basic normalized EPS0.686.263.82
Diluted normalized EPS0.685.913.82
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.